BeOne Medicines Ltd. (06160) Announces Q3 2025 Financial Results Release Date and Audit Committee Review

Bulletin Express

2025/10/22

BeOne Medicines Ltd. (06160) has announced that unaudited financial results for the third quarter ended September 30, 2025 will be released on Thursday, November 6, 2025, after trading hours of the Hong Kong Stock Exchange. These results, prepared in accordance with U.S. Generally Accepted Accounting Principles and the applicable rules of the U.S. Securities and Exchange Commission, will be reviewed and approved by the audit committee on the same day (Hong Kong Time).

Following the announcement, a conference call with the company’s management is scheduled for 8:00 a.m. U.S. Eastern Time on November 6, 2025 (9:00 p.m. Hong Kong Time). A live webcast will be accessible via the official investor relations section of the company's website, with an archived replay also made available. Participants are advised to register at least 15 minutes in advance for timely access.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1165894783"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1165894783\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1165894783?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-22 18:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1165894783","market":"us","top_or_hot":-1,"title":"BeOne Medicines Ltd. (06160) Announces Q3 2025 Financial Results Release Date and Audit Committee Review","media":"Bulletin Express","content":"<p>BeOne Medicines Ltd. (06160) has announced that unaudited financial results for the third quarter ended September 30, 2025 will be released on Thursday, November 6, 2025, after trading hours of the Hong Kong Stock Exchange. These results, prepared in accordance with U.S. Generally Accepted Accounting Principles and the applicable rules of the U.S. Securities and Exchange Commission, will be reviewed and approved by the audit committee on the same day (Hong Kong Time).</p>\n<p>Following the announcement, a conference call with the company’s management is scheduled for 8:00 a.m. U.S. Eastern Time on November 6, 2025 (9:00 p.m. Hong Kong Time). A live webcast will be accessible via the official investor relations section of the company's website, with an archived replay also made available. Participants are advised to register at least 15 minutes in advance for timely access.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BeOne Medicines Ltd. (06160) Announces Q3 2025 Financial Results Release Date and Audit Committee Review</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeOne Medicines Ltd. (06160) Announces Q3 2025 Financial Results Release Date and Audit Committee Review\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2025-10-22 18:47</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>BeOne Medicines Ltd. (06160) has announced that unaudited financial results for the third quarter ended September 30, 2025 will be released on Thursday, November 6, 2025, after trading hours of the Hong Kong Stock Exchange. These results, prepared in accordance with U.S. Generally Accepted Accounting Principles and the applicable rules of the U.S. Securities and Exchange Commission, will be reviewed and approved by the audit committee on the same day (Hong Kong Time).</p>\n<p>Following the announcement, a conference call with the company’s management is scheduled for 8:00 a.m. U.S. Eastern Time on November 6, 2025 (9:00 p.m. Hong Kong Time). A live webcast will be accessible via the official investor relations section of the company's website, with an archived replay also made available. Participants are advised to register at least 15 minutes in advance for timely access.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06160","symbol_name":"百濟神州","start_time":0,"source_url":"","article_id":"1165894783","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1165894783","pubTimestamp":1761130063,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"BeOne Medicines Ltd. (06160) has announced that unaudited financial results for the third quarter ended September 30, 2025 will be released on Thursday, November 6, 2025, after trading hours of the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06160":"百济神州"},"translate_title":"BeOne Medicines Ltd.(06160)公布2025年第三季度财务业绩发布日期和审计委员会审查","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06160":1},"content_text":"BeOne Medicines Ltd. (06160) has announced that unaudited financial results for the third quarter ended September 30, 2025 will be released on Thursday, November 6, 2025, after trading hours of the Hong Kong Stock Exchange. These results, prepared in accordance with U.S. Generally Accepted Accounting Principles and the applicable rules of the U.S. Securities and Exchange Commission, will be reviewed and approved by the audit committee on the same day (Hong Kong Time).\nFollowing the announcement, a conference call with the company’s management is scheduled for 8:00 a.m. U.S. Eastern Time on November 6, 2025 (9:00 p.m. Hong Kong Time). A live webcast will be accessible via the official investor relations section of the company's website, with an archived replay also made available. Participants are advised to register at least 15 minutes in advance for timely access.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}